Search Result "rapid virological response (RVR)"
Impact of Telaprevir in HCV Patients with Cirrhosis and RVR: Real-Life Data from Boceprevir or Telaprevir based âTriple Therapyâ Experience in Southern Italy
Journal: Reviews on Recent Clinical Trials
Volume: 11 Issue: 4 Year: 2016 Page: 306-316
Author(s): Filomena Morisco,Mario Masarone,Valerio Rosato,Silvia Camera,Rocco Granata,Maria T. Tartaglione,Carmine Coppola,Nicola Coppola,Angelo Salomone-Megna,Ivan Gentile,Antonio De Luna,Alessandro Federico,Davide Precone,Ernesto Claar,Ludovico Abenavoli,Marcello Persico
Population Pharmacokinetics and Pharmacodynamics of Albinterferon Alfa-2b in Patients Treated for Hepatitis C Virus Genotype 2/3
Journal: Anti-Infective Agents
Volume: 12 Issue: 1 Year: 2014 Page: 58-67
Author(s): Jing Yu,Haiying Sun,Maria Pang,Wan-Long Chuang,Shiv K. Sarin,Robert Flisiak,Daniel S. Stein
Predictability of Sustained Virological Response to Pegylated Interferon Alpha-2b Plus Ribavirin Therapy by Week-8 Viral Response in HIVPositive Patients with Chronic Hepatitis C Virus Infection
Journal: Current HIV Research
Volume: 7 Issue: 4 Year: 2009 Page: 447-455
Author(s): E. Angeli, A. Mainini, A. Cargnel, C. Uberti-Foppa, A. Orani, R. Carbone, M. Andreoni, M. Schiavini, R. Giorgi, G. Rizzardini, G. Gubertini
Impact of Dose Reduction on the Efficacy of Triple Therapy for Patients Infected with Genotype 1b and High Viral Loads
Ebook: Advances in Modern Medicine
Volume: 1 Year: 2017
Author(s): Hiroshi Kohno,Hirotaka Kouno,Toshiki Yamaguchi,Atsushi Yamaguchi,Toshio Kuwai
Doi: 10.2174/9781681080239117010032
HCV Carriers With Normal Alanine Aminotransferase Levels
Ebook: Preventive Female Sex Factors Against The Development of Chronic Liver Disease
Volume: 1 Year: 2012
Author(s): Claudio Puoti
Doi: 10.2174/978160805293611201010037
Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 12 Year: 2014 Page: 1391-1404
Author(s): I. Gentile,F. Borgia,N. Coppola,A.R. Buonomo,G. Castaldo,G. Borgia
Discovery and Development of Hepatitis C Virus Inhibitors Targeting the NS5A Protein
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 15 Issue: 7 Year: 2015 Page: 553-581
Author(s): Zhuangzhuang Yu,Liwen Zhao,Qi-Dong You
Determinants of Treatment Outcomes for Hepatitis C Infection and the Path to Personalized Medicine
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 9 Issue: 2 Year: 2011 Page: 123-136
Author(s): Sanaa M. Kamal
Telaprevir: A Promising Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
Journal: Current Medicinal Chemistry
Volume: 16 Issue: 9 Year: 2009 Page: 1115-1121
Author(s): I. Gentile, C. Viola, F. Borgia, G. Castaldo, G. Borgia
A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 30 Year: 2013 Page: 3733-3742
Author(s): I. Gentile,F. Borgia,A. R. Buonomo,G. Castaldo,G. Borgia